Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
Clinical trial NCT02631044 · COMPLETED
Trial details
- NCT number
- NCT02631044
- Sponsor
- Juno Therapeutics, a Subsidiary of Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-06
- Primary completion
- 2024-05-16
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.